Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats

被引:40
作者
Kaido, T
Yamaoka, S
Seto, S
Funaki, N
Kasamatsu, T
Tanaka, J
Nakamura, T
Imamura, M
机构
[1] KYOTO UNIV, SCH MED, DEPT SURG & SURG BASIC SCI, SAKYO KU, KYOTO 60601, JAPAN
[2] KYOTO UNIV, INST VIRUS RES, DEPT VIRAL ONCOL, SAKYO KU, F-75724 PARIS 15, FRANCE
[3] OSAKA UNIV, SCH MED, DIV BIOCHEM, CTR BIOMED RES, SUITA, OSAKA 565, JAPAN
来源
FEBS LETTERS | 1997年 / 411卷 / 2-3期
关键词
hepatocyte growth factor; CCl4; endotoxin; liver injury; protection;
D O I
10.1016/S0014-5793(97)00744-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We present a rat model in which continuous supply of hepatocyte growth factor (HGF) prevents liver injury induced by carbon tetrachloride (CCl4) and E. coli 011:B4 lipopolysaccharide (LPS), Rat fibroblasts genetically modified to secrete rat HGF were implanted in syngenic rat spleen 7 days before administration of the hepatotoxins. Rats with HGF-secreting fibroblasts in the spleen showed a dramatic resistance to CCl4- and LPS-induced liver injury, In the LPS-induced liver injury model, blood chemical analysis revealed that the increase in serum glutamic oxalacetic transaminase level and the decrease in blood sugar level were remarkably suppressed in rats with HGF-secreting cells in the spleen, Most importantly, their survival rate was greatly improved compared to other control groups of rats, Thus our results indicate a new role of HGF in liver protection during endotoxemia and convey important clinical implications for developing new therapeutic modalities in the treatment of liver failure caused by endotoxemia. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:378 / 382
页数:5
相关论文
共 40 条
  • [1] ADAMSON JW, 1991, CANCER, V67, P2708, DOI 10.1002/1097-0142(19910515)67:10+<2708::AID-CNCR2820671707>3.0.CO
  • [2] 2-A
  • [3] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION
    ANTMAN, KS
    GRIFFIN, JD
    ELIAS, A
    SOCINSKI, MA
    RYAN, L
    CANNISTRA, SA
    OETTE, D
    WHITLEY, M
    FREI, E
    SCHNIPPER, LE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) : 593 - 598
  • [4] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [5] BOSCH MA, 1988, BRIT J EXP PATHOL, V69, P805
  • [6] INVIVO STIMULATION OF GRANULOPOIESIS BY RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
    COHEN, AM
    ZSEBO, KM
    INOUE, H
    HINES, D
    BOONE, TC
    CHAZIN, VR
    TSAI, L
    RITCH, T
    SOUZA, LM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) : 2484 - 2488
  • [7] PREVENTION OF CARBON TETRACHLORIDE-INDUCED RAT-LIVER INJURY BY SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR
    CZAJA, MJ
    XU, J
    ALT, E
    [J]. GASTROENTEROLOGY, 1995, 108 (06) : 1849 - 1854
  • [8] ENDOGENOUSLY OPSONIZED PARTICLES DIVERT PROSTANOID ACTION FROM LETHAL TO PROTECTIVE IN MODELS OF EXPERIMENTAL ENDOTOXEMIA
    EIERMAN, DF
    YAGAMI, M
    ERME, SM
    MINCHEY, SR
    HARMON, PA
    PRATT, KJ
    JANOFF, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2815 - 2819
  • [9] The preventive effects of OK432 on endotoxin-induced liver injury: Liver protection by the modulation of hepatic macrophage function
    Fujita, S
    Arii, S
    Monden, K
    Ishiguro, S
    Nakamura, T
    Mizumoto, M
    Imamura, M
    [J]. SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1996, 26 (01): : 29 - 35
  • [10] MODE OF ACTION OF ANTI-LIPOPOLYSACCHARIDE-BINDING PROTEIN ANTIBODIES FOR PREVENTION OF ENDOTOXEMIC SHOCK IN MICE
    GALLAY, P
    HEUMANN, D
    LEROY, D
    BARRAS, C
    GLAUSER, MP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) : 7922 - 7926